ArticleJournal of cellular and molecular medicine2020

CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action.

Cheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.